Skip to main content

Table 1 Demographic, clinical and pathologic characteristics of the 287 subjects comprising the study cohort

From: Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature

Features Bladder cancer (%) N = 213 Controls (%) N = 74
Age (years)   
< 65 50 (23.5%) 74 (100.0%)
> 65 150 (70.4%) 0 (0.0%)
Unavailable 13 (6.1%)  
Sex   
Female 48 (24.0%) 16 (21.6%)
Male 152 (76.0%)  
Unavailable 13 (6.1%)  
Race   
Caucasian 162 (76.1%) %)  
Other 30 (14.0%)  
Unavailable 21 (9.9%)  
Tumor grade   
High-grade 175 (82.2%)  
Low-grade 26 (12.2%)  
Unavailable 12 (5.6%)  
Tumor stage   
Ta 49 (23.0%)  
Tis (CIS) 20 (9.4%)  
T1 62 (29.1%)  
T2 31 (14.6%)  
>T3, N+ or M+ 39 (18.3%)  
Unavailable 12 (5.6%)  
Recurrence   
Yes 70 (32.9%)  
No 143 (67.1%)